Haisco Pharmaceutical Group Co., Ltd.
Shenzhen Stock Exchange 002653.SZ
Haisco Pharmaceutical Group Co., Ltd. EBIT for the year ending December 31, 2023: USD 48.57 M
-
Haisco Pharmaceutical Group Co., Ltd. EBIT for the year ending December 31, 2022 was USD 65.84 M, a -22.19% change year over year.
-
Haisco Pharmaceutical Group Co., Ltd. EBIT for the year ending December 31, 2021 was USD 84.62 M, a -25.82% change year over year.
-
Haisco Pharmaceutical Group Co., Ltd. EBIT for the year ending December 31, 2020 was USD 114.08 M, a 33.66% change year over year.
-
Haisco Pharmaceutical Group Co., Ltd. EBIT for the year ending December 31, 2019 was USD 85.34 M, a 65.28% change year over year.
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
Don’t Miss A Beat
| CEO | Ms. Xiu Lian Fan |
| IPO Date | Jan. 17, 2012 |
| Location | China |
| Headquarters | No.17, Sanxiang Avenue |
| Employees | 5,448 |
| Sector | Health Care |
| Industries | |
Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive system, blood system, nervous system, parenteral nutrition, antibiotics, first aid, anesthetics, and tumor; and tablets, capsules, granules, and ointments in the fields of cardiovascular, anti-infection, digestive system, CNS system, diabetes, and hepatic diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.
Past 5 years
USD 1.88
USD 2.66
USD 3.88
USD 2.18
USD 4.11
StockViz Staff
January 30, 2025
Any question? Send us an email